Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.31 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.31 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | KDM4B | O94953 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6827215 | 0.82 | NR1I2 (0.38) | NR1I2KDM4BCHRM1TBXA2RADRA1A | |
| SCHEMBL7131529 | 0.80 | MLLT3 (0.40) | NR1I2KDM4BCHRM1TBXA2RADRA1A | |
| SCHEMBL6924594 | 0.79 | ALDH1A1 (0.35) | MKNK2NR1I2KDM4BCHRM1TBXA2R | |
| SCHEMBL6827693 | 0.78 | NPC1 (0.43) | — | |
| SCHEMBL6919056 | 0.76 | MLLT3 (0.44) | NR1I2KDM4BCHRM1TBXA2RADRA1A | |
| SCHEMBL6924757 | 0.76 | P4HTM (0.34) | MKNK1MKNK2P4HTM | |
| SCHEMBL7131791 | 0.76 | MLLT3 (0.39) | NR1I2KDM4BCHRM1TBXA2RADRA1A | |
| SCHEMBL6827359 | 0.74 | PGR (0.38) | NR1I2KDM4BCHRM1TBXA2RADRA1A | |
| SCHEMBL6824827 | 0.74 | PGR (0.38) | NR1I2KDM4BCHRM1TBXA2RADRA1A | |
| SCHEMBL6827087 | 0.73 | PGR (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004050624-A1 | SUBSTITUTED 1H-PYRIDINE-2-ONE DERIVATIVES | C & C RESEARCH LABORATORIES (KR) | 2004-06-17 | — | — | WO | disclosed |